PCRRF yields 2.89% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, PCRRF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PCRRF + MRK for your $10,000?
Pasco Corporation engages in the acquisition, analysis, and provision of geospatial information in Japan and internationally. It offers spaceborne services that handle data from the commercial earth observation satellites launched worldwide; and airborne surveying services, such as aerial photography, aerial laser, thermal sensor, hyperspectral sensor, oblique aerial photography, and airborne IFSAR surveying, as well as portable aerial photography and locator systems. The company also provides vehicle/ground surveying services, including road condition laser, road condition, global positioning system, total station, precision, and terrestrial laser surveying, as well as ground based InSAR and radar; and water area surveying services comprising bathymetry and seabed exploration. In addition, it offers geographic information system (GIS) cloud services for the municipalities and central government, cloud-based regional analysis and marketing services for the private companies, and reassurance with disaster prevention systems; customization and GIS application development; and geospatial information consulting services, including regional strategy analysis, disaster prevention and mitigation consultant, road and bridge design, water supply and sewage facility management, dam and port management, rivers and erosion control, mapping solutions, and maintenance services. The company was formerly known as Pacific Koku Sokuryo Co., Ltd. and changed its name to Pasco Corporation in 1983. The company was incorporated in 1949 and is headquartered in Tokyo, Japan. Pasco Corporation is a subsidiary of Secom Co., Ltd.
Full PCRRF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.